Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1067P, or "RNA, U6 small nuclear 1067, pseudogene," is a processed pseudogene of the U6 small nuclear RNA (snRNA) gene family. Unlike its functional parent, U6 snRNA, which is an essential and highly conserved component of the spliceosome mediating pre-mRNA splicing in the nucleus of eukaryotic cells, RNU6-1067P lacks the capacity to encode a functional RNA or protein and shows characteristics typical of processed pseudogenes—such as transcriptional inactivity and sequence mutations. The U6 snRNA gene family is notable for having many pseudogene copies in the vertebrate genome, reflecting the evolutionary importance and frequent retrotransposition of these sequences. While some pseudogenes have reported regulatory roles (e.g., miRNA sponging, regulation of parental genes), there is currently no evidence that RNU6-1067P is expressed, functional, or involved in disease biology. It is not a therapeutic target, nor does it have recognized clinical or pharmacological relevance. If you require more information on the functional U6 snRNA or other pseudogenes with established roles, please specify.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1067, pseudogene (RNU6-1067P).